A possible acting model for this chemoresistance induction is depicted in Figure 6 and illustrates that suppression of antitumor T-cell response via the interaction between PD-1 on effector T cells and induced PD-L1 on tumor cells may lead to this resistance of drug treatment. Here, PDCD1 is linked to neoplasm.